Lateral Flow Assays Market Growth Drivers and Challenges:
Growth Drivers
- Increasing Research Costs – The growth of the global lateral flow assays market is driven by increased investment in research and development activities. This helps to find more viable solutions for biosafety cabinets. Research reports show that global R&D spending has grown from around USD 680 billion to over USD 2.5 trillion in 2020.
- Growing Demand for Point-of-the-Care Testing – Point-of-the-care diagnostics devices have become increasingly important in recent years due to their ability to provide fast and accurate results in a variety of environments. Lateral flow assays are well suited to POCTs due to their simplicity, portability, and ease of use.
- Growing Demand for Food Safety Testing - The demand for food safety testing is increasing globally, due to factors such as the increasing incidence of foodborne illnesses, and safety regulations. Food changes and consumer awareness is increasing about the safety and quality of the food they eat. Side flow testing is widely used for food safety testing due to its ease of use, fast turnaround time, and ability to detect a wide range of contaminants such as pathogens, toxins, and allergens.
Challenges
- Lack of Sensitivity and Specificity – Lateral flow assays are known to have limitations in terms of sensitivity and specificity compared to other diagnostic methods, such as PCR or ELISA. This can lead to false-positive or false-negative results, which can be a significant challenge in various applications.
- Competition from Substitute Technologies
- Regulatory Limitations Associated
Lateral Flow Assays Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
6.2% |
|
Base Year Market Size (2025) |
USD 9.76 billion |
|
Forecast Year Market Size (2035) |
USD 17.81 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of lateral flow assays is assessed at USD 10.3 billion.
The global lateral flow assays market size surpassed USD 9.76 billion in 2025 and is projected to witness a CAGR of around 6.2%, crossing USD 17.81 billion revenue by 2035.
Asia Pacific lateral flow assays market will secure around 34% share by 2035, driven by high burden of infectious diseases requiring rapid diagnosis.
Key players in the market include Abbott Laboratories, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffmann-La Roche AG, QIAGEN N.V., Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Merck kGaA, PerkinElmer Inc.
